Table 4.
Distribution of viral diseases and neoplasia among HIV-positive adults newly hospitalized from April to September 2010, IeDEA West Africa Collaboration
| Classification, N (%)a | Diagnosis, N | |||||||
|---|---|---|---|---|---|---|---|---|
| Suspected | ||||||||
| N (%)a | AIDS | WHO stage 4 | WHO stage 3 | Presumptive | Definitive | Suspected IRIS, N | Adverse effect, N | |
| Total number of patients | 824 (100) | 445 (100) | 388 (100) | 232 (100) | 45 | 45 | ||
| Viral diseases | ||||||||
| CMV infectionb | 3 (0.4) | 3 (0.7) | 3 (0.8) | – | 3 | 1 | ||
| Herpes infectionc | 10 (1.1) | 5 (1.1) | 5 (1.3) | 10 | – | |||
| HIV encephalopathy | 19 (2.3) | 19 (4.2) | 19 (4.9) | 16 | 3 | |||
| Molluscum contagiosum | 3 (0.4) | 1 | 2 | |||||
| PML | 1 (0.1) | 1 (0.2) | 1 (0.3) | 1 | – | |||
| VZV infection | 1 (0.1) | – | 1 | |||||
| Viral hepatitis B | 17 (2.1) | – | 17 | |||||
| Tumour | ||||||||
| Invasive cervix carcinoma | 2 (0.2) | 2 (0.4) | 2 (0.5) | – | 2 | |||
| Kaposi sarcoma | 21 (2.5) | 21 (4.7) | 21 (5.4) | 10 | 11 | 3 | ||
| NHL | 8 (1.0) | 8 (1.8) | 8 (2.0) | 5 | 3 | |||
| Hepatocarcinoma | 4 (0.5) | 3 | 1 | |||||
| Other tumorsd | 6 (0.7) | 1 | 5 | |||||
| In situ cervical intraepithelial neoplasis | 4 (0.5) | – | 4 | |||||
| Benign tumour or tumour of unspecified evolution | 7 (0.8) | 3 | 4 | |||||
CMV: cytomegalovirus; PML: progressive multifocal encephalopathy; VZV: varicella zoster virus; NHL: non-Hodgkin lymphoma.
a
Several illnesses may have occurred during the hospitalization of a given patient;
b
CMV infection: localization non-specified;
c
herpes infection: genital (n=4), oral (n=2), anal (n=2), meningitis (n=1), cutaneous (n=1), digestive (n=1);
d
other cancers: multiple myeloma (n=1), pancreas cancer (n=1), ano-rectal cancer (n=1), abdominal tumour (n=1), ENT cancer (n=1), epidermoid carcinoma of the eye (n=1).